Barbara Klencke
Director/Board Member at EFFECTOR THERAPEUTICS, INC.
Net worth: 400 950 $ as of 30/04/2024
Profile
Barbara J.
Klencke is currently a Director at Xencor, Inc., a Director at Immune-Onc Therapeutics, Inc., an Independent Director at TScan Therapeutics, Inc., and an Independent Director at eFFECTOR Therapeutics, Inc. Previously, she held positions such as Medical Director at Chiron Corp., Group Medical Director-Product Development at Genentech, Inc., Senior Vice President-Clinical Development at Onyx Pharmaceuticals, Inc., and Chief Medical & Development Officer at Sierra Oncology, Inc. She also served as an Independent Director at Lexent Bio, Inc. Dr. Klencke received her undergraduate degree from Indiana University and her doctorate from the University of California, Davis.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TSCAN THERAPEUTICS, INC.
0.12% | 14/12/2023 | 55,000 ( 0.12% ) | 400 950 $ | 30/04/2024 |
| 18/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Barbara Klencke active positions
| Companies | Position | Start |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Director/Board Member | 01/11/2021 |
| TSCAN THERAPEUTICS, INC. | Director/Board Member | 06/04/2023 |
| XENCOR, INC. | Director/Board Member | 15/09/2023 |
Immune-Onc Therapeutics, Inc.
 Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Director/Board Member | 08/11/2022 |
Former positions of Barbara Klencke
| Companies | Position | End |
|---|---|---|
| SIERRA ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 01/07/2022 |
Lexent Bio, Inc.
 Lexent Bio, Inc. Financial ConglomeratesFinance Lexent Bio, Inc. engages in the development of novel liquid biopsy technologies to manage cancer. The company was founded by Kenneth G. Nesmith, Haluk Tezcan, and John Spinosa and is headquartered in San Francisco, CA. | Director/Board Member | 01/01/2020 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/06/2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2011 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/07/2003 |
Training of Barbara Klencke
| Indiana University | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| XENCOR, INC. | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| EFFECTOR THERAPEUTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Health Technology |
Lexent Bio, Inc.
Lexent Bio, Inc. Financial ConglomeratesFinance Lexent Bio, Inc. engages in the development of novel liquid biopsy technologies to manage cancer. The company was founded by Kenneth G. Nesmith, Haluk Tezcan, and John Spinosa and is headquartered in San Francisco, CA. | Finance |
- Stock Market
- Insiders
- Barbara Klencke